Abstract:Human sirtuins play important roles in various cellular events including DNA repair, gene silencing, mitochondrial biogenesis, insulin secretion as well as apoptosis. They regulate a wide array of protein and enzyme targets through their NAD+‐dependent deacetylase activities. Sirtuins are also thought to mediate the beneficial effects of low‐calorie intake to extend longevity in diverse organisms from yeast to mammals. Small molecules mimicking calorie restriction to stimulate sirtuin activity are attractive therapeutics against age‐related disorders such as cardiovascular diseases, diabetes and neurodegeneration. Little is known about one of the mitochondrial sirtuins, SIRT5. SIRT5 has emerged as a critical player in maintaining cardiac health and neuronal viability upon stress, and functions as a tumor suppressor in a context‐specific manner. Much has been debated about whether SIRT5 has evolved away from being a deacetylase because of its weak catalytic activity, especially in the in vitro testing. We have, for the first time, identified a SIRT5‐selective allosteric activator, nicotinamide riboside (NR). It can increase SIRT5 catalytic efficiency with different synthetic peptide substrates. The mechanism of action was further explored using a combination of molecular biology and biochemical strategies. Based on the existing structural biology information, the NR binding site was also mapped out. These activators are powerful chemical probes for the elucidation of cellular regulations and biological functions of SIRT5. The knowledge gained in the current study can be used to guide the design and synthesis of more potent, isotype‐selective SIRT5 activators, and to develop them into therapeutics for metabolic disorders and age‐related diseases.

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

Specific Turn-On Fluorescent Probe With Aggregation-Induced Emission Characteristics For Sirt1 Modulator Screening And Living-Cell Imaging

Fluorogenic Assays for the Defatty-Acylase Activity of Sirtuins.

Deacetylation-activated construction of single quantum dot-based nanosensor for sirtuin 1 assay

A One-Step Specific Assay for Continuous Detection of Sirtuin 2 Activity

Interactions of SIRT1 with Acetyl Substrate, NAD+ or Nicotinamide

Bioluminescence Assay of Lysine Deacylase Sirtuin Activity

Continuous Sirtuin/HDAC (histone deacetylase) activity assay using thioamides as PET (Photoinduced Electron Transfer)-based fluorescence quencher

Sensitive Fluorogenic Substrates for Sirtuin Deacylase Inhibitor Discovery.

A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors

Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.

Mechanism-based affinity capture of sirtuins.

Interactions Between Sirtuins and Fluorogenic Small-Molecule Substrates Offer Insights into Inhibitor Design

The NAD+-dependent Protein Deacetylase Activity of SIRT1 is Regulated by Its Oligomeric Status

New insight into molecular mechanisms of different polyphenols affecting Sirtuin 3 deacetylation activity

Nicotinamide Riboside Activates SIRT5 Deacetylation

A Near Infrared Fluorescent Probe for One-Step Detection of Histone Deacetylase Activity Based on an Intramolecular FRET

Acetylome Study in Mouse Adipocytes Identifies Targets of SIRT1 Deacetylation in Chromatin Organization and RNA Processing.

A Novel Mechanism for SIRT1 Activators That Does Not Rely on the Chemical Moiety Immediately C-Terminal to the Acetyl-Lysine of the Substrate

Assessment of Mitochondrial Dysfunctions after Sirtuin Inhibition.

G-quadruplex-based Fluorometric Biosensor for Label-Free and Homogenous Detection of Protein Acetylation-Related Enzymes Activities.